Clinical development regulatory approval rate
Proportion of drug candidates entering clinical trials that successfully receive regulatory marketing authorization.
Unit Percent Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Clinical development regulatory approval rate
United States, end of 2025
Every record
All records
1 record · 1 region · 2025
| Period | Value | Source | Type |
|---|---|---|---|
| United States 1 record | |||
| end of 2025 | 12% | PhRMA · 31 Dec 2025 | estimate |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Research & Development | PhRMA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Clinical development regulatory approval rate. Retrieved from https://statorigin.org/indicators/clinical-development-regulatory-approval-rate